Insights

Innovative Delivery Platform ApiJect's focus on low-cost, prefilled, single-use injection devices presents a significant opportunity to meet growing demand for safer, more reliable vaccine and medication delivery solutions, especially in regions with high injection reuse risks.

Strong Funding Support Recent grants from the Bill and Melinda Gates Foundation and substantial equipment financing of 35 million dollars demonstrate strong investor confidence, enabling ApiJect to accelerate development and scaling efforts, which can be leveraged for partnership and procurement opportunities.

Strategic Industry Partnerships Collaborations like the recent partnership with Amneal Pharmaceuticals expand ApiJect's capacity for sterile manufacturing and blow-fill-seal capabilities, opening doors for joint ventures to supply innovative injection devices globally.

Market Growth Potential Targeting the global need for affordable and safe injection devices positions ApiJect well within expanding markets driven by increasing vaccination rates, emerging healthcare systems, and the push for safer injection practices worldwide.

Technology and Innovation Focus Utilizing advanced manufacturing methods with raw materials like pharmaceutical-grade polymers and aiming for lightweight, durable, break-resistant containers provides opportunities to offer cutting-edge, cost-effective solutions to healthcare providers and governments seeking to upgrade their injection infrastructure.

Similar companies to ApiJect Systems

ApiJect Systems Tech Stack

ApiJect Systems uses 8 technology products and services including HubSpot Analytics, Webpack, Slick, and more. Explore ApiJect Systems's tech stack below.

  • HubSpot Analytics
    Analytics
  • Webpack
    Development
  • Slick
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • ZURB Foundation
    UI Frameworks
  • Piwik PRO Core
    Web Analytics
  • Google Plus
    Widgets

Media & News

ApiJect Systems's Email Address Formats

ApiJect Systems uses at least 1 format(s):
ApiJect Systems Email FormatsExamplePercentage
FLast@apiject.comJDoe@apiject.com
76%
LFirst@apiject.comDJohn@apiject.com
12%
First@apiject.comJohn@apiject.com
10%
FirstLast@apiject.comJohnDoe@apiject.com
2%

Frequently Asked Questions

What is ApiJect Systems's official website and social media links?

Minus sign iconPlus sign icon
ApiJect Systems's official website is apiject.com and has social profiles on LinkedInCrunchbase.

What is ApiJect Systems's NAICS code?

Minus sign iconPlus sign icon
ApiJect Systems's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ApiJect Systems have currently?

Minus sign iconPlus sign icon
As of December 2025, ApiJect Systems has approximately 57 employees across 2 continents, including North AmericaEurope. Key team members include Chief Partnerships Officer: N. R.Chief People Officer: A. S.Chief Operating Officer: M. W.. Explore ApiJect Systems's employee directory with LeadIQ.

What industry does ApiJect Systems belong to?

Minus sign iconPlus sign icon
ApiJect Systems operates in the Pharmaceutical Manufacturing industry.

What technology does ApiJect Systems use?

Minus sign iconPlus sign icon
ApiJect Systems's tech stack includes HubSpot AnalyticsWebpackSlickModernizrYoast SEOZURB FoundationPiwik PRO CoreGoogle Plus.

What is ApiJect Systems's email format?

Minus sign iconPlus sign icon
ApiJect Systems's email format typically follows the pattern of FLast@apiject.com. Find more ApiJect Systems email formats with LeadIQ.

How much funding has ApiJect Systems raised to date?

Minus sign iconPlus sign icon
As of December 2025, ApiJect Systems has raised $425K in funding. The last funding round occurred on Oct 24, 2024 for $425K.

When was ApiJect Systems founded?

Minus sign iconPlus sign icon
ApiJect Systems was founded in 2016.

ApiJect Systems

Pharmaceutical ManufacturingConnecticut, United States51-200 Employees

Welcome to Apiject, where our platform makes it possible for all injections everywhere to be delivered in a low-cost, prefilled device anyone can use.

We start with an aseptically-filled Blow-Fill-Seal container prefilled with a single dose and then combine it with a pen needle hub. The single primary raw material, pharmaceutical-grade polymer resin, ensures safety and reliability, while the absence of glass makes it lightweight and break-resistant. 
Our injector cannot be refilled, mitigating the risk of syringe reuse that currently causes 1.3 million deaths annually. We envision a future where every country can reliably meet its citizens' needs for safe, smart, single-use, and universally accessible medical injections.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $425K

    ApiJect Systems has raised a total of $425K of funding over 3 rounds. Their latest funding round was raised on Oct 24, 2024 in the amount of $425K.

  • $10M$25M

    ApiJect Systems's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $425K

    ApiJect Systems has raised a total of $425K of funding over 3 rounds. Their latest funding round was raised on Oct 24, 2024 in the amount of $425K.

  • $10M$25M

    ApiJect Systems's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.